Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug

Enlivex pledged commercially reasonable efforts to hold the shareholder vote within 60 days, while the second $400 million remains optional. The post Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug appeared first on CryptoS...

Source: [CryptoSlate](https://cryptoslate.com/biotech-company-asks-shareholders-to-dilute-stock-by-951-to-hoard-illiquid-crypto-token-instead-of-funding-its-own-drug/)